GlassScriptPhysician profile
Pradeep Pallati
NPI 1033323274
$11,720.06
in general payments reported to CMS, 2019-2025
19 companies · $1,381 in 2025
The $1,381 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.54 · 2022: $5,130 · 2023: $3,346 · 2024: $1,846 · 2025: $1,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,020 · Travel and Lodging: $2,099 · Food and Beverage: $1,446 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,020.00 |
| Travel and Lodging | $2,099.10 |
| Food and Beverage | $1,445.67 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,430.90 | 2022-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $1,306.29 | 2022-2024 | Endo Gia Ultra |
| Horizon Therapeutics Plc | $125.02 | 2022 | |
| Amgen INC. | $120.13 | 2025 | Tavneos |
| Alexion Pharmaceuticals, INC. | $115.64 | 2023 | Ultomiris |
| Innovation Technologies INC | $81.74 | 2024 | Irrisept |
| Smith+Nephew, INC. | $73.66 | 2024 | Collagenase Santyl |
| Csl Behring | $70.06 | 2023 | Kcentra |
| Stryker Corporation | $68.94 | 2023-2024 | Spy-Phi System |
| Polynovo North America LLC | $58.00 | 2023-2025 | Novosorb Btm |
| Tela Bio, INC. | $54.20 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Pacira Pharmaceuticals Incorporated | $41.70 | 2024 | Exparel |
| Boston Scientific Corporation | $37.46 | 2025 | Overstitch Endoscopic Suturing System |
| Becton, Dickinson and Company | $36.13 | 2023-2025 | Phasix Mesh |
| Molli Surgical (US) INC | $31.58 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.98 | 2023 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2023 | Gattex |
| Shire North American Group INC | $16.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.77 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Pallati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.